New drug shows promise in reducing COPD symptoms in smokers, clinical trials show
(NEW YORK) -- A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and current smokers, according to results from late-stage clinical trials.The medication, called tozorakimab and developed by AstraZeneca, is the first biologic drug to show efficacy in treating COPD symptoms, according to Dr. Frank Sciurba, professor of Pulmonary and Critical Care Medicine, University of Pittsburgh, in an AstraZeneca press […]